Activation of blood clotting and fibrinolysis in angiocardiography with ionic and non-ionic contrast medium;Aktivierung von blutgerinnung und fibrinolyse nach angiokardiographie mit ionischem und nichtionischem kontrastmittel

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 166, Issue 6, 1997, Pages 539-543

  Winkler, U H ^d   Park, J W ^a   Weber, S ^d   Kothe, A ^d   Schnitker, J ^b   Behrends Steins, B ^d   Albring, M ^c  

^a Herz Zentrum Kaiser Wilhelm Krankhs   (Germany)

^b Inst F Angewandte Statistik GmbH   (Germany)

^c BAYER PHARMA AG   (Germany)

^d NONE

Author keywords

Angiocardiography; Blood clotting; Fibrinolysis; Ionic non ionic x ray contrast medium

Indexed keywords

DIATRIZOATE; IOPROMIDE;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANGIOCARDIOGRAPHY; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIATRIZOATE; DOUBLE-BLIND METHOD; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; IOHEXOL; MIDDLE AGED; THROMBIN; TIME FACTORS;

EID: 0030877391     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Stormorken, H.: Effects of contrast media on the hemostatic and thrombotic mechanisms. Invest. Radiol. 23 (1988) 318-325
2. Robertson, H. J. F.: Blood clot formation in angiographic syringes containing nonionic contrast media. Radiology 163 (1987) 621-622
3. Dawson, P.: Chemotoxicity of contrast agents and clinical adverse effects. Invest. Radiol. 20 (1985) 584-591
4. Fareed, J., J. M. Walenga, G. E. Saravia, R. M. Moncada: Thrombogenic potential of nonionic contrast media? Radiology 174 (1990) 321-325
5. Judkins, M. P., M. P. Gander: Prevention of complications of coronary arteriography. Circulation 49 (1974) 599-602
6. Bauer, K. A.: The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 79 (1987) 343-348
7. Kluft, C., J. H. Verhijen: Leiden fibrinolysis, working party: Blood collecting and handling procedures for assessment of tissue type plasminogenactivator (A-PA) and plasminogenactivatorinhibitor (PAI 1). Fibrinolysis 4 (1990) 155-161
8. Jespersen, J., R. M. Bertina, F. Haverkate (eds.): ECAT-assay procedures: a manual of laboratory techniques. Kluwer Academic Publishers, Dordrecht, NL (1992)
9. Cortellaro, M., C. Bosdhetti, E. Cofranesco et al.: The PLAT study: a multidisziplinary study of hemostatic function and conventional risk vactors in vascular disease patients. Atherosclerosis 90 (1991) 109-118
10. Lüscher, T. F., F. C. Tanner, M. R. Tschudi, G. Noll: Endothelial dysfunction in coronary artery disease. Ann. Rev. Med. 44 (1993) 395-418
11. Dawson, P.: The clotting issue: etiologic factors in thromboembolism. I. Chemistry, pharmacology, and toxicity of angiographic contrast agents. Invest. Radiol. 38 (1993) 25-30